Culture Collection (ATCC) standard Mycobacterium species and 5 Korean Type Culture Collection (KTCC) standard Mycobacterium species ( Table 1) . The HPLC instrument was equipped with Waters 2690 separation module (Milford, MA), reverse phase analytical cartridge column, 3.9 × 75 mm, packed with 3 μm silica (Nova-Pak C18), and photodiode array detector (Waters Corporation, Milford, MA). For internal standards for low-and high-molecular weight, 6,7-dimethoxy-4-coumarinylmethyl ester and p-bromophenyl ester were used, respectively.
The HPLC samples were prepared by cell harvesting, saponification, extraction, and a clarification to isolate mycolic acids. The procedure involved a whole cell saponification, acidification, and methanolic extraction of all cellular fatty acids, including the mycolic acids. Mycobacteria were removed from a 3% Ogawa slant or Mycobacteria Growth Indicator Tube with a sterile polyester swab and placed in 2 mL of saponification reagent composed of 25% potassium hydroxide in a water methanol (1:1) mixture. The suspension was vigorously mixed and autoclaved for 1 hour at 121°C. After the mixture was cooled to room temperature, 2 mL of chloroform was added followed by 1.5 mL acidification reagent and a mixture of water and concentrated hydrochloric acid (1:1). This solution was mixed and the organic/aqueous layers were separated. The lower, organic layer was transferred with a Pasteur pipette to a new tube and evaporated in a heat block at 85°C-105°C with a stream of air. The commercial derivatization reagent was suspended in acetonitrile and consisted of p-bromophenacyl bromide p-bromophenacyl ester (PBPA) and a crown ether catalyst. A mycolic acid sample was derivatized to PBPA esters by adding 20 mg of potassium bicarbonate, 50 μL of derivatization reagent, and 1.0 mL of chloroform. The tubes were secured with Teflon-lined screw caps and heated at 85°C to 105°C for 20 minutes. Samples were cooled and then filtered through a 0.45-μm-pore-size nylon 66 membrane filter.
The prepared samples were subjected to HPLC analysis using UV detector. The HPLC peaks, which were shown between low-and high-molecular weight standards, were first separated into single, double, triple, and multiple cluster patterns. Each cluster group was identified by its number of peaks, retention times, and relative peak heights.
From the AFB HPLC pattern analysis, single cluster (Figures 1, 2 , and 3). Multi-cluster groups showing more than 4 peak clusters were not included in this study since they are yet to be confirmed as infectious. 6 Highperformance liquid chromatography patterns, which did not match with any of 33 standard Mycobacterium species, were included as 'unclassified' NTM.
Results

Identification of Mycobacteria Species Using HPLC
During the study period, a total of 24,778 clinical specimens of various types from 13,241 patients were collected. (Figure 2) were identified, whereas only 1 species, M. simiae was found in the triple-cluster group and no species were found in the multi-cluster group 6 (Figure 3 ). Additionally, identical species were identified from all patients with multiple specimens who were culture positive for AFB.
Distribution of NTM
Among 3212 isolates from 1421 patients, 2824 isolates (87.9%) from 1218 patients (85.7%) were identified as M. tuberculosis and the rest were classified as NTM. Among the 388 NTM isolates, the prevalence of the various species ranged between 15.5% to <1% ( Table 2) .
Consistent with the distribution of types of clinical specimens, most NTM were isolated from sputa, pleural fluid, and bronchial aspirates (74.7%), but NTM were identified in other specimen types (25.3%): urine (7.0%), skin (5.9%), lymph node (5.7%), pus (2.6%), cerebrospinal fluid (CSF) (1.6%), gastric aspirates (1.3%), bone marrow (0.8%), and joint fluid (0.5%).
When we investigated trends, NTM species detected in >5% of specimens (M. Table 3) . However, when compared to the 1981-1994 study period, 34 there was a decrease in M. avium-intracellulare, M. fortuitum, and M. chelonae but an increase in M. kansasii and M. gordonae.
A national survey of mycobacterial disease other than tuberculosis in Korea conducted by the Scientific Committee in the Korean Academy of Tuberculosis and Respiratory Disease for 14 years between 1981 and 1994 reported that 158 isolates out of 159 isolates, which were admitted to the Korean National Tuberculosis Association for infection examination, were identified as NTM by biochemical methods. 34 In this report, NTM species distribution was: 104 cases in M. avium-intracellulare (65.2%); 20 in M. fortuitum (12.7%); 15 in M. chelonae (9.5%); 7 cases in M. gordonae avium-intracellulare and M. terrae (0.6%). The present study showed that between 2005 and 2009, NTM infections reported in Ulsan, South Korea, were 2.5 times higher than the rate between 1981 and 1994.
Discussion
Species-specific mycobacterial identification in clinical specimens is an essential step for the diagnosis of mycobacterial infection. Until now, more than 91 NTM species were reported, 10 but more than 30% of NTM species, detected from water, soil, air, and humans, were estimated to exist but have yet to be reported to cause human disease. 35 The widely used biochemical methods for mycobacterial identification are limited in their sensitivity, time needed, and difficulty in discriminating species level. Also, identification methods using PCR and gene probe assay are known to be fast and accurate in their species level detection, but these methods include some chances for contamination. Therefore, they have a high degree of false-positive results, are difficult to evaluate for various mycobacterial species, and often require multiple steps to identify species level. 2, [22] [23] [24] [25] 27, 33 However, HPLC methods, employed in this study and reported by others, used species-specific mycolic acid for analysis, and these can overcome the drawbacks mentioned above. [3] [4] [5] [6] 15 We used the 33 standard Mycobacterium species for HPLC comparison and found that 3195 of our isolates (99.5%) had matching HPLC patterns. When excluding tuberculosis isolates, 371 NTM isolates (95.6%) were speciated.
In our hospital a HPLC machine is available, and the cost per sample is $4 United States dollars. This would equate to $12,848 spent to screen the 3212 samples in this study. This would compare favorably to PCR-based methods that would cost $40 per sample.
In 1960, the occurrence rate of NTM infections by AFB culture in South Korea was less than 1%, 17, 20 and in 1970 Kim and colleagues reported a rate in sputum at 2.7%. 18 The present study found the rate of NTM among all AFB culture positive specimens to have a 12.1% occurrence rate and a 14.3% patient rate. This suggests our AFB culture methods have improved for NTM, our diagnostic suspicion has improved to obtain AFB-positive samples, or, more likely, the incidence of NTM infections in South Korea has significantly increased since 1960-1970. Although there are only a few reports of NTM species rate and distribution, a national survey of mycobacterial diseases other than tuberculosis in Korea conducted by the Scientific Committee in the Korean Academy of Tuberculosis and Respiratory Disease for 14 years between 1981 and 1994 reported that 158 isolates out of the 159 isolates admitted to the Korean National Tuberculosis Association for infection examination were identified as NTM by biochemical methods. 34 Notably, the present study indicated that between 2005 and 2009, NTM infections reported in Ulsan, South Korea, were 2.5 times higher than the rate between 1981 and 1995. This difference in occurrence may in part be due to the fact that this study used HPLC, while the Scientific Committee in Korean Academy of Tuberculosis and Respiratory Disease used biochemical tests for the identification of mycobacteria. 34 The increase may indicate that the NTM infection rate is escalating and also that the HPLC method is more precise than standard biochemical methods in discriminating species. However, based on the fact that the species found in more than 5% in this study (M. kansasii, M. intracellulare, M. gordonae, M. avium, M. fortuitum, M. abscessus, M. peregrinum, and M. szulgai) showed no increase for 5 years, we conclude that the increased number of species found in this study is most likely the result of using the more sensitive HPLC method.
In species distribution, M. avium complexes including M. avium and M. intracellulare were found the most (24.7%) in this study, but when compared to the national survey of mycobacterial diseases other than tuberculosis in Korea (65.2%), these mycobacteria species decreased by 40.5% when compared to the 1981-1994 study. 34 Species M. fortuitum and M. chelonae were found 8.0% and 1.6% respectively in this study, whereas in the 1995 data they were 12.7% and 9.5%. Mycobacterium kansasii increased by 14.2% (from 1.3% to 15.5%), M. gordonae by 7.2% (from 4.4% to 11.6%), and M. szulgai by 2.9% (from 1.3% to 5.2%). The following 5 new species were found: M. abscessus (5.9%), M. peregrinum (5.7%), M. marinum (3.6%), M. mucogenicum (3.6%), and M. xenopi (2.6%). The changes in the NTM species distribution are similar to the data provided by U.S. Centers for Disease Control and Prevention (surveyed from 1993 to 1996), 7 indicating the current method is valid for evaluation. Interesting to note, Koh and colleagues reported in 2006 that NTM from respiratory specimens are mainly M. avium complex (48%) and M. abscessus (33%). 19 However, this study evidenced the significant increase of M. kansasii, which may be due to the fact that our data pool includes respiratory and non-respiratory specimens and also reflects the local characteristics of a high endemicity of M. kansasii. 39 We found in this study that, like tuberculosis, the NTM species was found the most in respiratory systems including sputum, bronchial aspirates, and pleural fluid (290 cases, 74.8%) and in variable amounts in non-respiratory systems including urine, skin or tissue, lymph node, pus, CSF, gastric aspirates, bone marrow, and joint fluid.
Conclusion
In conclusion, HPLC methods speciated 99.5% of mycobacteria cultured from clinical specimens and 95.6% of NTM species. Among the inspected mycobacteria, 20 species were identified NTM (12.1%). Based on this study, the epidemiology of NTM seems to be changing in South Korea, showing that M. avium-intracellulare, M. fortuitum, and M. chelonae have been decreasing in prevalence, while M. kansasii and M. gordonae have been relatively increasing. This study also validated HPLC as a useful method for speciating AFB-positive cultures, which is practical for diagnosis and proper treatment thereafter. This study also establishes a benchmark in South Korea for mycobacterial distribution, which will be useful for future mycobacteria investigations. LM
